Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice

Published:2017-04-28 Issue:8 Volume:60 Page:1475-1482
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Grönholm Juha,Pagni Philippe P.,Pham Minh N.,Gibson Claire B.,Macomber Paul F.,Vela José Luis,von Herrath Matthias,Lenardo Michael J.

Funder

Sigrid Juséliuksen Säätiö

Wellstat Immunotherapeutics Corp

Wellstat Diagnostics, LLC

Novo Nordisk

National Institute of Allergy and Infectious Diseases

Emil Aaltosen Säätiö

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s00125-017-4276-5/fulltext.html

Reference29 articles.

1. Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69–82

2. Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447–485

3. Unanue ER (2014) Antigen presentation in the autoimmune diabetes of the NOD mouse. Annu Rev Immunol 32:579–608

4. Reed JC, Herold KC (2015) Thinking bedside at the bench: the NOD mouse model of T1DM. Nat Rev Endocrinol 11:308–314

5. Nakayama M, Abiru N, Moriyama H et al (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220–223

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes;Frontiers in Immunology;2024-03-07

2. CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome;Frontiers in Pharmacology;2022-03-18

3. Altered islet prohormone processing: a cause or consequence of diabetes?;Physiological Reviews;2022-01-01

4. Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes;Cell Metabolism;2019-04

5. The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes;Frontiers in Medicine;2018-10-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3